The retail pharmacy giant saw its revenue increase 8.3 percent in the first quarter and its pharmacy revenue increase by 4.2 percent, according to a May 6 news release.
Its earnings per share were $1.91 and total revenue was $66.8 billion in the first quarter. The company said it expects its 2020 earnings to be between $7.04 to $7.17 per share.
The pandemic caused more customers to order 90-day prescriptions, CVS said, causing its total pharmacy claims processed to increase by 12.4 percent.
CVS also plans to ramp up COVID-19 testing by opening 1,000 testing sites across the country.
Read the full earnings report here.
More articles on pharmacy:
Gilead gets FDA emergency use authorization for remdesivir
AmerisourceBergen offers to buy Walgreens’ drug wholesaling division
CVS says it will boost access to mental health services
